American Migraine Foundation Highlights HeadaTerm2 in Its Latest Device Recommendations, Backed by Clinical Evidence
VANCOUVER, BC, June 16, 2025 /PRNewswire/ — WAT Medical Enterprise Ltd. is pleased to announce that its migraine relief device, HeadaTerm 2, is now featured on the American Migraine Foundation’s (AMF) updated Device Corner, a patient education resource highlighting FDA-cleared neuromodulation devices for migraine treatment. HeadaTerm 2 is a non-invasive, drug-free device designed to help manage migraine symptoms through external trigeminal
